Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Immunology (Orlando, Fla.)|October 14, 2010
Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human liversRashmi Singh, Jay Bullard, Mamta Kalra, et al.Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.JAMA Oncology|April 21, 2017
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita Brawley, Meenakshi Hegde, et al.Journal for Immunotherapy of Cancer|July 22, 2024
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumorsMartin Wermke, Tobias A W Holderried, Jason John Luke, et al.Nature Cancer|April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trialMeenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.Nature Medicine|April 9, 2025
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trialMartin Wermke, Dejka M Araujo, Manik Chatterjee, et al.Pageof 2